ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Number of cancer stem cells might not predict outcome in HPV-related oral … – Medical Xpress

Number of cancer stem cells might not predict outcome in HPV-related oral …Medical Xpress(Medical Xpress)—New research from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that it may be the quality of cancer stem cells rather … and more …read … Continue reading

2014-01-22 Michael Zand NEWS

Stem Cell Tumors: Getting Their Fix on the Fly – Bowdoin News

Stem Cell Tumors: Getting Their Fix on the FlyBowdoin NewsMichele Markstein’s laboratory uses the fruit fly Drosophila melanogaster as an in vivo incubator to grow and study stem cell tumors. This approach preserves the integrity of the stem cell microenvironment, a feat not yet readily possible by … …read more   &nbs… Continue reading

2014-01-22 Michael Zand NEWS

Novel platform for the Propagation of Stem Cells using Alvetex 3D cell Culture … – Labmate Online

Novel platform for the Propagation of Stem Cells using Alvetex 3D cell Culture …Labmate Online“We are excited about bringing this new method for 3D stem cell propagation to the market,‟ said Richard Rowling, Commercial Director of Reinnervate Ltd. “Allowing pluripotent stem cells to retain their natural 3D structure during passaging offers a … …read more   &nbs… Continue reading

2014-01-22 Michael Zand NEWS

2013: Stem cell research’s new partnership of science and ethics – Daily Caller

2013: Stem cell research’s new partnership of science and ethicsDaily CallerThe year just ended saw some major developments in medicine, not the least of which involved the consolidation of trends in the controversial area of stem cell research. And the big news is that this research is rapidly evolving, in ways quite … …read more   &nbs… Continue reading

2014-01-21 Michael Zand NEWS

Antisense Therapeutics wins approval for stem cell cancer treatment trial in … – Proactive Investors Australia

Antisense Therapeutics wins approval for stem cell cancer treatment trial in …Proactive Investors Australia… has won approval for a stem cell cancer treatment trial in Melbourne. Antisense Therapeutics (ASX:ANP) should trade firmer after receiving approval to conduct a Phase 1 Stem Cell Mobilisation Human Proof of Concept trial for its anticancer drug … …read more   &nbs… Continue reading

2014-01-21 Michael Zand NEWS

New Stem Cell Procedure Gives Hope To Pain Sufferers – CBS Local

New Stem Cell Procedure Gives Hope To Pain SufferersCBS LocalPITTSBURGH (NewsRadio 1020 KDKA) — Stem cells have been used to treat cancer patients, multiple sclerosis and other conditions. Now, a local practice, Rehabilitation and Pain Specialists, is bringing to the Pittsburgh area a non-surgical adult stem … …read more   &nbs… Continue reading

2014-01-21 Michael Zand NEWS

HUB Foundation for Organoid Technology signs licensing agreement with … – News-Medical.net

HUB Foundation for Organoid Technology signs licensing agreement with …News-Medical.netThe HUB Foundation for Organoid Technology announced today that it has signed a licensing agreement with STEMCELL Technologies Inc. for the manufacturing and worldwide distribution of cell culture media for growing Organoids. Organoids are … and more …read more   &nbs… Continue reading

2014-01-21 Michael Zand NEWS

Pluristem stem cell trial to treat muscle injury meets main goal – Fox News

Pluristem stem cell trial to treat muscle injury meets main goalFox NewsPluristem Therapeutics Inc said results from its early/mid-stage clinical trial indicated its placenta-derived stem cells for the treatment of muscle injury were safe and provided evidence the cells might be effective in treating orthopedic injuries … …read more   &nbs… Continue reading

2014-01-21 Michael Zand NEWS
  • 1
  • …
  • 3,311
  • 3,312
  • 3,313
  • 3,314
  • 3,315
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.